Abstract
In this study, antibacterial effects of (+)-Medioresinol isolated from stem bark of Sambucus williamsii and its synergistic activities in combination with antibiotics such as ampicillin, cefotaxime, and chloramphenicol were tested by antibacterial susceptibility testing and checkerboard assay. (+)-Medioresinol possessed antibacterial effects against antibiotics-susceptible- or antibiotics-resistant strains. Most of combinations between (+)-Medioresinol and each antibiotic showed synergistic interaction (fractional inhibitory concentration index ≤0.5) against bacterial strains including antibiotics-resistant Pseudomonas aeruginosa. Furthermore, the antibiofilm effect of (+)-Medioresinol alone or in combination with each antibiotic was investigated. The results indicated that not only (+)-Medioresinol but also its combination with each antibiotic had antibiofilm activities. It concludes that (+)-Medioresinol has potential as a therapeutic agent and adjuvant for treatment of bacterial infection.
Similar content being viewed by others
References
Mesaros, N., Nordmann, P., Plesiat, P., Van Roussel-Delvallez, M., Eldere, J., Glupczynski, Y. V., et al. (2007). Clinical Microbiology and Infection, 13, 560–5787.
Nishanth Kumar, S., Siji, J. V., Nambisan, B., & Mohandas, C. (2012). World Journal of Microbiology and Biotechnology, 28, 3143–3150.
Beringer, P. M. (1999). Current Opinion in Pulmonary Medicine, 5, 371–377.
Chung, P. Y., Parasakthi, N., & Chung, L. Y. (2011). Annals of Clinical Microbiology and Antimicrobials, 10, 1–6.
Lee, Y., Jang, K., & Cha, J. (2012). Journal of Biomedicine and Biotechnology, 618081, 1–7.
Hoiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010). International Journal of Antimicrobial Agents, 35, 322–332.
Lynch, S. V., Dixon, L., Benoit, M. R., Brodie, E. L., Keyhan, M., Hu, P., et al. (2007). Antimicrobial Agents and Chemotherapy, 51, 3650–3658.
Liaqat, I., & Sabri, A. N. (2008). Journal of Basic Microbiology, 49, 1–10.
Boyer, J., & Liu, R. H. (2004). Nutrition Journal, 3, 5.
Zakay-Rones, Z., Varsano, N., Zlotnik, M., Manor, O., Regev, L., Schlesinger, M., et al. (1995). Journal of Alternative and Complementary Medicine, 1, 361–369.
Ahmadiani, A., Fereidoni, M., Semnanian, S., Kamalinejad, M., & Saremi, S. (1998). Journal of Ethnopharmacology, 61, 229–235.
Xie, F., Wu, C. F., Zhang, Y., Yao, X. S., Cheung, P. Y., Chan, A. S., & Wong, M. S. (2005). Biological and Pharmaceutical Bulletin, 28, 1879–1885.
Yan, Z. H., Yang, C. H., Wu, X. H., & Xie, Y. Y. (2004). Chinese Chemical Letters, 15, 408–410.
Hwang, J. H., Hwang, I. S., Liu, Q. H., Woo, E. R., & Lee, D. G. (2012). Biochimie, 94, 1784–1793.
Li, C. Y., & Li, Y. C. (1999). Acta Pharmaceutica Sinica, 34, 605–607.
Zhou, L. X., & Dind, Y. (2000). Zhongguo Zhong Yao Za Zhi, 25, 541–543.
CLSI. (2005). Performance standards for antimicrobial susceptibility testing. Wayne: CLSI.
Eliopoulos, G. M., & Moellering, R. C. (1991). Antimicrobial combinations. In V. Lorian (Ed.), Antibiotics in laboratory medicine (pp. 432–492). Baltimore: Williams & Wilkins.
NCCLS. (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National committee for clinical Laboratory Standards USA M7-A6.
Pankey, G. A., & Ashcraft, D. S. (2005). Antimicrobial Agents and Chemotherapy, 49, 2959–2964.
Odds, F. C. (2003). Journal of Antimicrobial Chemotherapy, 52, 1.
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., et al. (1985). Journal of Clinical Microbiology, 22, 996–1006.
Wei, G. X., Campagna, A. N., & Bobek, L. A. (2006). Journal of Antimicrobial Chemotherapy, 57, 1100–1109.
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). Nature Reviews Microbiology, 8, 423–435.
William, F., Marshall, M. D., Janis, E., & Blair, M. D. (1999). Mayo Clinic Proceedings, 74, 187–195.
An, J., Zuo, G. Y., Haob, X. Y., Wanga, G. C., & Li, Z. S. (2011). Phytomedicine, 18, 990–993.
Gradelski, E., Valera, L., Bonner, D., & Fung-Tomc, J. (2001). Antimicrobial Agents and Chemotherapy, 45, 3220–3222.
White, R. L., Burgess, D. S., Manduru, M., & Bosso, J. A. (1996). Antimicrobial Agents and Chemotherapy, 40, 1914–1918.
Mushtaq, S., Ge, Y., & Livermore, D. M. (2004). Antimicrobial Agents and Chemotherapy, 48, 3086–3092.
Hancock, R. E. (1985). Antibiotics and Chemotherapy, 36, 95–102.
Buyck, J. M., Plésiat, P., Traore, H., Vanderbist, F., Van Tulkens, P. M., & Bambeke, F. (2012). Clinical Infectious Diseases, 55, 534–542.
Acknowledgments
This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MEST) (no. 2008-0062618).
Author information
Authors and Affiliations
Corresponding author
Additional information
Ji Hong Hwang and Hyemin Choi contributed equally to this work and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Hwang, J.H., Choi, H., Hwang, Is. et al. Synergistic Antibacterial and Antibiofilm Effect Between (+)-Medioresinol and Antibiotics In Vitro. Appl Biochem Biotechnol 170, 1934–1941 (2013). https://doi.org/10.1007/s12010-013-0351-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0351-7